TABLE 1.
Characteristics of participants (n = 1065)
| Characteristics | n (%), M ± SD (IQR) |
|---|---|
| Age | 65.00 ± 11.42 (27–96) |
| 27–40 | 45 (4.23) |
| 41–65 | 497 (46.67) |
| 66–80 | 445 (41.78) |
| ≥81 | 78 (7.32) |
| Gender | |
| Male | 353 (33.15) |
| Female | 712 (66.85) |
| Ethnicity | |
| Han | 1062 (99.72) |
| Minority | 3 (0.28) |
| Education attainment | |
| Primary school or below | 49 (4.60) |
| Secondary school | 696 (65.35) |
| Post‐secondary | 179 (16.81) |
| University or above | 141 (13.24) |
| Marital status | |
| Married | 930 (87.32) |
| Single | 135 (12.68) |
| Employment | |
| Yes, full‐time job | 85 (7.98) |
| Yes, part‐time job | 733 (68.83) |
| Otherwise | 247 (23.19) |
| Primary caregiver | |
| Spouse | 890 (83.57) |
| Children | 272 (25.54) |
| Parents | 62 (5.82) |
| Self | 17 (1.60) |
| Type of cancer | |
| Gastrointestinal cancer | 241 (22.63) |
| Gynecologic cancer | 57 (5.35) |
| Urinary cancer | 86 (8.08) |
| Blood cancer | 31 (2.91) |
| Breast cancer | 312 (29.30) |
| Lung cancer | 154 (14.46) |
| Head and neck | 157 (14.74) |
| Brain cancer | 13 (1.22) |
| Otherwise | 34 (3.19) |
| Stage of cancer | |
| I | 417 (39.15) |
| II | 430 (40.38) |
| III | 113 (10.61) |
| IV | 40 (3.76) |
| Not clear | 65 (6.10) |
| Duration of cancer survivorships (year) | 5.46 ± 4.87 (0.5–26.0) |
| Types of received therapy | |
| Surgery | 42 (3.94) |
| Chemotherapy | 113 (10.61) |
| Radiotherapy | 29 (2.72) |
| Endocrine therapy | 143 (13.43) |
| Biological targeted therapy | 40 (3.76) |
| Immunotherapy | 121 (11.36) |
| Chinese medicine therapy | 545 (51.17) |
| Interventional therapy | 4 (0.38) |
| Otherwise | 79 (7.42) |
| Comorbidities | |
| Hypertension | 458 (43.00) |
| Diabetes | 194 (18.22) |
| Cardiovascular disease | 151 (14.18) |
| Otherwise | 49 (4.60) |
| No comorbidities | 496 (46.57) |